Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies

Hussein A. Abbas, William G. Wierda

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences